For leaders in life sciences · Biotech · Pharma · Medical Technology

FDA‑confident AI Solutions and
AI governance
without the audit scramble.

Your next FDA inspection may already be on the calendar. We help life sciences companies We help life sciences organizations pass audits with confidence and reduce validation burden—accelerating time to go-live with the people, process, and AI-driven technology behind modern CSA, QMS transformation, and responsible AI governance.

25+
Years in in quality
and compliance
60+
Life Sciences
clients globally
FDA
Key contributor of CSA guidance
FDA‑Industry CSA Team (FICSA) chair
AI-native
Proprietary CLAiRE,
MAiGRATE & iQuality™
Trusted by life sciences leaders · Partnerships
/ / / / /
Certifications
TUV SUD

ISO/IEC 42001: 2023 Certified

Ethical and Well-Governed AI Secure, Transparent & Accountable Systems Scalable, Trust-Driven Innovation

SOC 2

SOC 2 Type 2 Compliant

Independently audited controls Proven operational effectiveness Security, availability & confidentiality assured

ISO 27001

ISO/IEC 27001:2022 Certified

International information security standard Risk-based security management system Strong data protection & governance

You're not imagining it

Quality leaders are being asked to do more with less—while FDA expectations get sharper.

The Quality Management System Regulation (QMSR) is live. CSA is reshaping validation. AI governance expectations are arriving faster than policies. And you're carrying inspection accountability while the team scales faster than the quality system can keep up.

If any of these feel familiar, you're not behind—you're exactly where the industry is. The question is whether you're set up to turn it into an advantage or a remediation project.

Validation drag is slowing launches.

Legacy validation approaches burn cycles on documentation instead of risk. Product timelines slip while validation teams script tests no auditor will ever read.

AI is in the building—governance isn't.

Your teams are already using Artificial Intelligence for classification, summarization, and decision support. But there's no defensible framework, no International Organization for Standardization / International Electrotechnical Commission (ISO/IEC) 42001 posture, and no audit-ready trail.

Audit trail reviews are a manual fire drill.

Multiple systems, multiple sub-modules, and no one has time to read them. Inspection prep becomes a war room instead of a standing capability.

Tribal knowledge is your biggest risk.

Change impact analysis depends on one or two experts. When they leave, institutional memory walks out with them—right before the next Pre-Approval Inspection (PAI).

Legacy Quality Management Systems (QMS) cost $1M+ and take 12–18 months.

You need a modern QMS and Document Management System (DMS), but not an enterprise implementation that consumes a year of executive bandwidth and half a budget cycle.

Staff augmentation treats you like a req, not a program.

Generic consultancies send bodies. You need people who already know CSA, GAMP 5 v2, 21 Code of Federal Regulations (CFR) Part 11 and Annex 11, International Electrotechnical Commission (IEC) 62304, and how your tools actually work.

The Industry Shift

Most life sciences organizations are dangerously behind on AI governance—and the FDA is already asking questions.

— Khaled Moussally · FDA–Industry CSA Team (FICSA)
Velocity Gap
3×

Faster validation cycle times for companies that modernized to CSA early versus those still following the 1998 CSV playbook.

Cost Exposure
$1M+

Typical cost of a single FDA Form 483 observation that triggers remediation, delayed approval, or re-submission cycles.

Closing Window
18 mo

Between FDA's final CSA guidance (2024–25) and when inspection expectations catch up to peer companies already implementing it.

A plan you can actually execute

Three steps to turn compliance into competitive velocity.

We don't drop a 200-page report and leave. We assess, roadmap, and stay—so your team builds the muscle to sustain it after we're gone.

01
Assess

Free AI & CSA Readiness Assessment

45 minutes with Khaled Moussally, FDA CSA Guidance Leader, or a senior CSA lead. We score your AI governance posture, validation approach, and inspection readiness against FDA's latest guidance—then show you exactly where the gaps are.

45 min · No cost · Actionable
02
Roadmap

CSA & AI Governance Roadmap

We build the 90-day and 12-month plan: what to validate risk-based, where to apply AI, which Standard Operating Procedures (SOPs) to rewrite, and what to staff. Sequenced by audit risk and launch dependencies—not by whoever shouts loudest.

4–6 weeks · Fixed fee
03
Sustain

iQuality™ platform + Managed Services

Our AI-native QMS / DMS replaces the "digital filing cabinet" with continuous compliance intelligence (Document Xcellence – DX live now, Validation Xcellence – VX & Quality Xcellence – QX coming). Wrapped with managed services from the team that wrote the guidance.

From launch · Ongoing partnership
Meet Your Guide

We didn't just read the CSA guidance. We co-authored it.

Before Compliance Group existed in 2017, our team had been practicing Computer Systems Validation (CSV) and CSA for 15+ years. When the FDA set out to modernize software validation, our Executive Vice President (EVP) Khaled Moussally chaired the FDA–Industry CSA Team (FICSA)— the only consulting firm in the consortium. He remains on the ISPE GAMP 5 v2 steering committee.

That's why Sarepta, Vericel, Regeneron and 60+ other life sciences organizations run multi-year managed services programs with us. We're not a resourcing firm that picked up compliance work. We're the subject matter experts your peers call when they need it done right.

FDA Credential
FICSA Chair

Chair of the FDA–Industry CSA Team. Co-authored sections of the final CSA guidance.

Industry Body
ISPE GAMP 5

Co-authored GAMP 5 Second Edition. Active steering committee member.

Partnerships
Siemens Polarion

Certified implementation partner for Application Lifecycle Management (ALM), design controls, and traceability programs.

Proprietary AI
CLAiRE + MAiGRATE

Agentic AI built for Life Sciences. AI-pipeline tooling for data migration pain.

Client Trust
60+ clients

Including top-tier biotech and medical technology innovators. 95% of business is referral-driven.

Governance
ISO/IEC 42001

Our platform is built to the international AI management system standard. Plus ISO 27001 & System and Organization Controls (SOC) 2 Type II.

Integrated Service Pillars

People, process, and AI-powered technology—in one partner.

Most firms force you to choose: a consultancy, a resourcing agency, or a software vendor. We operate as all three, coordinated under one account team—so your compliance program gets consistent brains, hands, and tools.

01 / Consulting

Expert Consulting

CSA transformation, QMSR readiness, AI governance frameworks, audit remediation, GxP advisory, and FDA inspection preparation—led by practitioners, not generalists.

CSA / CSV QMSR AI Governance 21 CFR Part 11 Audit Readiness
02 / Technology

AI-Powered Technology Solutions

Siemens Polarion (ALM, design controls, requirements management). Veeva Vault implementations and managed services. Proprietary CLAiRE and MAiGRATE AI. And iQuality™— our own AI-native QMS platform.

Polarion ALM Veeva Vault iQuality™ CLAiRE MAiGRATE
03 / resourcing

Specialized Life Sciences resourcing

CSV/CSA validators, Quality Assurance (QA) leads, Regulatory Affairs (RA) specialists, Polarion engineers, Veeva admins. On-shore, near-shore, off-shore, or hybrid. Flexible engagement—not a stack of resumes you have to re-interview.

Staff Augmentation Managed Team Contract-to-Hire Project-based
04 / OCM

Organizational Change Management & Microlearning

Compliance initiatives fail when people don't adopt. We design role-based change programs and microlearning that drive actual adoption of new SOPs, platforms, and risk-based thinking—so the work sticks.

OCM Strategy Microlearning Training Design Adoption
Life after the engagement

What it looks like when compliance compounds.

  • Inspections become a standing capability, not a scramble.

    Audit-ready evidence is continuous. Your team walks into PAIs with the same story the system tells.

  • Validation cycles shorten by 30–60%.

    Risk-based CSA replaces cover-yourself scripting. Teams spend time on the work that actually matters to patient safety.

  • AI becomes a defensible advantage—not an audit risk.

    An ISO/IEC 42001-aligned AI posture your board, your regulators, and your auditors can all understand.

  • Your quality team stops being the bottleneck to launch.

    Product, Information Technology (IT), and Quality align on a shared roadmap. Compliance accelerates innovation instead of blocking it.

Your Next Move

Book your free AI & CSA Readiness Assessment.

45 minutes with a senior CSA lead. You'll walk away with a scored readiness snapshot, the top three gaps we'd fix first, and a clear view of what a 90-day plan would cost. No pitch deck. No obligation.

45 minutes Practitioner-led Actionable output Zero obligation
Learn & Connect

Upcoming Events & Webinars

Stay informed with upcoming events, live webinars, and expert-led industry sessions.

Hello, how can we help you?
claire-chat-icon